Ishita Drugs & Industries Ltd
company logo

Ishita Drugs & Industries Ltd

ISHITADRUGS Share Price

BSE:524400

80.45

4.43 (5.83%)

As on April 10, 2026 at 04:00 PM
Loading chart...

Performance

Loading performance...

76.02

79

5213

0.04

10

Fundamentals

24.05Cr

27.09

2.14

0.19

2.97

0%

37.58

About

Ishita Drugs & Industries Limited was incorporated in February, 1992 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. The company supplies its products to leading pharmaceutical companies of India. The products are also being exported to various countries across the world. The plant has been designed and constructed to meet GMP norms. The genesis of the Ishita Group in 1992 was the result of the entrepreneurial spirit of Mr. Jagdish Agrawal, who set up a reactive dye manufacturing unit in Ahmedabad. Buoyed by the growth of its first Venture, the Group made its maiden foray in the pharma sector in 1981 by setting up a small Bulk drugs plant at Surendranagar in Gujarat, to cater to the need of Pharma industry for Quality Products. The Bulk Drugs Industry at that point of time was highly dependent on costly imports and the growth was not achievable. The Company gradually formed a vertically integrated industry chain covering Drug Intermediates, Active Pharma Ingredients (APIs), excipients and finished dosage forms. The Group has 3 manufacturing facilities located in Gujarat, 2 for APIs and drug intermediates (at Ahmedabad and Surendranagar) and 1 for finished pharmaceutical formulations (at Mehsana). Thereafter, the Company set up a project to manufacture bulk drugs at Sanand, in the Ahmedabad district of Gujarat with an installed capacity of 408 tpa. Commercial production commenced in Jan.'95. It established an in-house R&D laboratory which has developed a highly improved process technology for norfloxacin, which was implemented in the plant during Oct.'95. The Company in 2009 undertook a small expansion cum-debottlenecking project; it upgraded many existing equipments. During the year 2023-24, the GMP certification of the manufacturing facility of the Company was renewed by the regulatory authorities.

Jagdish Agrawal

1992

NameDesignation
Jagdish AgrawalManaging Director
Abha AgrawalNon Executive Director
Arvind SapkalIndependent Non Exe. Director
Dhwani Jaypalsinh SolankiIndependent Non Exe. Director
Srushti PandyaCompany Sec. & Compli. Officer

Ishita Drugs & Industries Ltd FAQs

How do I Buy Ishita Drugs & Industries Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Ishita Drugs & Industries Ltd shares in BlinkX.

What is the Share Price of Ishita Drugs & Industries Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Ishita Drugs & Industries Ltd's share price is ₹80.45 as of 2026-04-12.

What is the PE ratio of Ishita Drugs & Industries Ltd?

close

Ishita Drugs & Industries Ltd's P/E ratio is 27.09 times as of 2026-04-12.

What is the PB ratio of Ishita Drugs & Industries Ltd?

close

Ishita Drugs & Industries Ltd's most recent financial reports indicate a price-to-book ratio of 2.14, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Ishita Drugs & Industries Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Ishita Drugs & Industries Ltd's market capitalization is ₹24.05 Cr as on 2026-04-12.

What is the ROE of Ishita Drugs & Industries Ltd?

close

The current financial records of Ishita Drugs & Industries Ltd show a 8.4% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Ishita Drugs & Industries Ltd?

close

According to Ishita Drugs & Industries Ltd's most recent financial filings, the company has a total asset value of ₹11.47, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Ishita Drugs & Industries Ltd?

close

The 52-week high/low price of a Ishita Drugs & Industries Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Ishita Drugs & Industries Ltd's 52-week high and low as of 2026-04-12 are ₹90.85 and ₹66, respectively.